The effectiveness of new migraine treatments has been compared to paracetamol in a new study, which suggests drugs developed in the 1990s should be more widely promoted to patients with the ...

The FDA is poised to issue a decision soon on KarXT, a potential first-in-class antipsychotic for schizophrenia. What should ...

In the tests, the antidepressant vortioxetine performed best and was “exceptionally consistent,” according to the study, ...

FRIDAY, Sept. 20, 2024 (HealthDay News) -- Would-be dads don’t have to worry that taking the epilepsy drug valproate will ...

When states legalize medical and recreational cannabis, fewer prescriptions for anxiety are filled, but more for depression ...

Data from the federal government shows that Mississippi consistently ranks in the top five in the nation for its rates of ...

The comparative efficacy and tolerability of oral migraine medications suggest four triptans are superior to the newer, more ...

Recent research has found that high-dose prescription amphetamines, often used to treat ADHD, are linked to a seriously ...

A new analysis found that high doses of stimulants prescribed for ADHD came with a 5-fold increased risk of experiencing ...

Ketamine use disorder/ketamine addiction is being recognized as an emerging addictive disorder. Ketamine, an essential ...

Depression, defined by (World Health Organization, n.d.-b) states, “Depressive disorder, or depression, is a common mental health condition that can happen to anyone. It is characterized by a low mood ...